MEDICINE & HEALTH

Cybin Inc.

Cybin Enters Definitive Agreement to Acquire Small Pharma

Cybin Inc. (NYSE American:CYBN) (NEO:CYBN), a biopharmaceutical company dedicated to transforming mental healthcare through developing psychedelic-based treatment options, and Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF), a biotech company that focuses on developing short-duration psychedelic therapies for mental health conditions, announced that they have entered into a agreement pursuant to which Cybin will acquire all of Small Pharma's issued and outstanding securities in an all-share deal.
81 82 83 84 85 86 87 88 89 90  

Recommended Stories

Real Time Analytics